The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosis. Bittner S, Bauer MA, Ehling P, Bobak N, Breuer J, Herrmann AM, Golfels M, Wiendl H, Budde T, Meuth SG Exp Neurol. 2012 Aug 27. PMID: 22960185. Abstract CommentRecommendBookmarkWatch